Diffusion MRI Brain Region Counting for Myelin Alteration Assessment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for evaluating brain alterations in demyelinating diseases like multiple sclerosis, adrenomyeloneuropathy, and amyotrophic lateral sclerosis lack robust and efficient biomarkers that are quick to obtain and easy to understand, often leading to false-positive or false-negative results, and require time-consuming learning phases.
Innovation Solution
A method and system using diffusion tensor MRI to determine an indicator of brain alteration by calculating regional diffusion coefficients for specific brain regions, comparing them to healthy patient averages, and counting altered regions to provide a concise and quantitative assessment of myelin alteration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional MRI biomarkers are used to evaluate brain alterations in demyelinating diseases, then the evaluation can be performed, but the results are not robust and lead to false-positive or false-negative results
Solution Approach 1:
The method divides the brain into multiple predefined regions of interest (such as corpus callosum, internal capsule, cerebral peduncles, etc.) and evaluates diffusion coefficients in each region separately. This segmentation allows for more precise localization and characterization of demyelinating lesions, improving both reliability and measurement precision by avoiding false positives from diffuse abnormalities and false negatives from localized lesions.
Solution Approach 2:
The invention applies different evaluation criteria and reference ranges to different brain regions based on their specific anatomical and physiological characteristics. Each region of interest is assessed against region-specific normative data, allowing for accurate detection of demyelination in each location while accounting for normal variations in diffusion properties across different brain areas.
2Measurement precision
If complex classification methods are used to determine disease probability, then detection accuracy may improve, but the method requires time-consuming learning phases and is restrictive
Solution Approach 1:
The method uses pre-established reference ranges and normative data for diffusion coefficients in various brain regions, which are determined beforehand from healthy control populations. This preliminary preparation eliminates the need for time-consuming learning phases during patient evaluation, as the classification criteria are already defined and validated, enabling rapid and accurate assessment without restrictive training requirements.
Solution Approach 2:
The invention transforms complex classification problems into simpler parameter-based assessments by focusing on specific diffusion coefficient parameters (radial, axial, and mean diffusion coefficients) with predefined threshold values and reference ranges. This parameter-based approach maintains detection accuracy while dramatically reducing computational complexity and eliminating the need for machine learning training phases.
3Measurement precision
If detailed and complex biomarkers are used to assess brain alteration, then measurement precision improves, but ease of operation and understanding for healthcare professionals deteriorates
Solution Approach 1:
The method presents results in a segmented format showing the number and location of altered regions of interest, rather than overwhelming healthcare professionals with complex continuous data. This segmentation into discrete, countable regions with clear anatomical labels improves ease of operation and interpretation while maintaining measurement precision through systematic evaluation of each region.
Solution Approach 2:
The invention extracts and highlights only the most clinically relevant information - the number of altered regions and their locations - from the full set of diffusion coefficient measurements. This extraction of key findings from complex data maintains measurement precision while dramatically improving ease of operation and understanding for healthcare professionals by presenting only essential diagnostic information.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Provides a simple, rapid, and robust indicator of brain alteration that is easy to understand, allowing healthcare professionals to evaluate severity and progression of demyelinating diseases, correlating with disability scales and aiding in treatment effectiveness assessment.
Implementation Method 1
diffusion tensor MRI to evaluating the degree of brain alteration
Implementation Method 2
magnetic resonance imaging (MRI) and more particularly diffusion tensor MRI
Data Source
AI summary
A method for determination of an indicator representative of a change in the brain caused by a demyelinating disease, the method including, for each region of interest of the brain, determining a regional coefficient of one of the following diffusion coefficients: the radial diffusion, the axial diffusion, the mean diffusion, the anisotropy fraction, or a combination of several of these coefficients, the regional coefficients being determined from a diffusion MRI image; determining a number of changed regions, for which a condition relating to the value of the regional diffusion coefficient of each region is satisfied; and determining the indicator in accordance with the number of changed regions.